aldeA Ventures

aldeA Ventures is a Barcelona, Spain-based venture capital firm dedicated to fostering innovation within the life sciences sector. Operating as a catalyst for the innovation economy, the firm primarily focuses on early-stage companies developing disruptive technologies. Their investment thesis centers on identifying and supporting promising ventures in biotechnology, medical technology (medtech), and digital health, aiming to drive significant advancements in healthcare. Founded by Managing Partners Josep Lluis Sanfeliu and Albert Ferrer, aldeA Ventures leverages deep industry expertise to guide its portfolio companies from their nascent stages.

The firm typically invests in Seed and Series A funding rounds, providing crucial capital to nascent companies. aldeA Ventures' initial investment range is between €500,000 and €2,000,000, which translates to approximately $540,000 to $2,160,000 USD based on current exchange rates. Beyond the initial cheque, the firm is prepared to make follow-on investments, potentially deploying up to €5,000,000 (approximately $5,400,000 USD) per company over its lifecycle, demonstrating a long-term commitment to its portfolio. This strategic approach ensures that companies receive sustained financial backing as they scale and mature.

aldeA Ventures manages its investments through its fund, aldeA Ventures I, which has a total funding amount of €20,000,000 (approximately $21,600,000 USD). As of recent data, the firm has made at least 10 investments, showcasing its active role in the European life sciences ecosystem. Their portfolio reflects a diverse range of companies, all aligned with their core focus on innovative healthcare solutions. By concentrating on early-stage ventures with high growth potential, aldeA Ventures aims to not only generate financial returns but also contribute to the development of groundbreaking medical technologies and therapies that can significantly impact global health.